Literature DB >> 29141851

A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and Progression.

Suzanne Dufresne1, Amélie Rébillard1, Paola Muti2, Christine M Friedenreich3,4,5, Darren R Brenner6,4,5.   

Abstract

The role of circulating miRNAs (c-miRNAs) in carcinogenesis has garnered considerable scientific interest. miRNAs may contribute actively to cancer development and progression, making them potential targets for cancer prevention and therapy. Lifestyle factors such as physical activity (PA) have been shown to alter c-miRNA expression, but the subsequent impact on cancer risk and prognosis is unknown. To provide a better understanding of how PA reduces the risk of cancer incidence and improves patient outcomes, we conducted a review of the impact of PA on c-miRNA expression, which includes a comprehensive synthesis of studies examining the impacts of acute and chronic exercise on expression of c-miRNAs. While the variability in methods used to assess miRNA expression creates challenges in comparing and/or synthesizing the literature, results to date suggest that the circulating form of several miRNAs known for playing a role in cancer (c-miR-133, c-miR-221/222, c-miR-126, and c-let-7) are altered by both acute and chronic PA. Additional research should develop standardized procedures for assessing both c-miRNA and PA measurement to improve the comparability of research results regarding the direction and amplitude of changes in c-miRNAs in response to PA. Cancer Epidemiol Biomarkers Prev; 27(1); 11-24. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29141851     DOI: 10.1158/1055-9965.EPI-16-0969

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

1.  Exercise-Induced Circulating microRNAs: Potential Key Factors in the Control of Breast Cancer.

Authors:  Guilherme Defante Telles; Miguel Soares Conceição; Felipe Cassaro Vechin; Cleiton Augusto Libardi; Marcelo Alves da Silva Mori; Sophie Derchain; Carlos Ugrinowitsch
Journal:  Front Physiol       Date:  2022-06-16       Impact factor: 4.755

2.  Regulation of mi-RNAs Target Cancer Genes Between Exercise and Non-exercise in Rat Rheumatoid Arthritis Induction: Pilot Study.

Authors:  Vimolmas Tansathitaya; Witchana Sarasin; Tanapati Phakham; Vorthon Sawaswong; Prangwalai Chanchaem; Sunchai Payungporn
Journal:  Epigenet Insights       Date:  2022-06-29

3.  MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA.

Authors:  Hanwen Chen; Shuming Gao; Cai Cheng
Journal:  Hum Cell       Date:  2018-08-07       Impact factor: 4.174

4.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

5.  A Physically Active Status Affects the Circulating Profile of Cancer-Associated miRNAs.

Authors:  Martina Faraldi; Laura Gerosa; Marta Gomarasca; Veronica Sansoni; Silvia Perego; Ewa Ziemann; Giuseppe Banfi; Giovanni Lombardi
Journal:  Diagnostics (Basel)       Date:  2021-04-30

6.  MiR-150-3p targets SP1 and suppresses the growth of glioma cells.

Authors:  Zhigang Tan; Jiaoying Jia; Yugang Jiang
Journal:  Biosci Rep       Date:  2018-05-15       Impact factor: 3.840

7.  Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.

Authors:  Hisashi Uwatoko; Yuka Hama; Ikuko Takahashi Iwata; Shinichi Shirai; Masaaki Matsushima; Ichiro Yabe; Jun Utsumi; Hidenao Sasaki
Journal:  Mol Brain       Date:  2019-05-14       Impact factor: 4.041

Review 8.  Exercise shapes redox signaling in cancer.

Authors:  Mohamad Assi; Suzanne Dufresne; Amélie Rébillard
Journal:  Redox Biol       Date:  2020-01-18       Impact factor: 11.799

9.  MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.

Authors:  Yu You; Keting Que; Yun Zhou; Zhen Zhang; Xiaoping Zhao; Jianpin Gong; Zuojin Liu
Journal:  Mol Cells       Date:  2018-08-27       Impact factor: 5.034

10.  MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway.

Authors:  Shiqi Kong; Yingxiao Cao; Xin Li; Zhenzhong Li; Yuling Xin; Yan Meng
Journal:  J Cell Mol Med       Date:  2020-03-17       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.